Article Information
History
- November 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- F. Hodel1,2,
- A.Y. Chong3,
- P. Scepanovic4,
- Z.M. Xu1,2,
- O. Naret1,2,
- C.W. Thorball1,5,
- S. Rüeger6,
- P. Marques-Vidal7,
- P. Vollenweider7,
- M. Begemann8,
- H. Ehrenreich8,
- N. Brenner9,
- N. Bender9,
- T. Waterboer9,
- A. J. Mentzer3,10,
- A.V.S. Hill3,11,
- C. Hammer12,13,*,† and
- J. Fellay1,2,5,*,†
- 1Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland
- 2Swiss Institute of Bioinformatics, Lausanne, Switzerland
- 3The Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
- 4Roche Pharmaceutical Research and Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 5Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 6Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland
- 7Department of Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 8Clinical Neuroscience, Max Planck Institute of Experimental Medicine, DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Göttingen, Germany
- 9Infections and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
- 10Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK
- 11The Jenner Institute, University of Oxford, Oxford, UK
- 12Department of Cancer Immunology, Genentech, South San Francisco, CA, USA
- 13Department of Human Genetics, Genentech, South San Francisco, CA, USA
- ↵*Corresponding authors; email: jacques.fellay{at}epfl.ch
↵† Equal contribution